Abaloparatide Dosage Guide
Complete guide to Abaloparatide dosing protocols, administration methods, and safety considerations for research purposes.
Detailed Dosage Information
Prescription-only medicine.
Dosing is set by a physician according to the FDA-approved label and the condition being treated.
Administration Method
Administration details not available for this peptide.
Research Backing
FDA prescribing information (Tymlos). ACTIVE phase 3 trial (JAMA 2016).
Side Effects to Monitor
Dizziness, nausea, headache, palpitations, fast heart rate and raised calcium in the urine.
Safety Considerations & Risks
Orthostatic hypotension around the time of injection, high blood calcium and kidney stones. Osteosarcoma was seen in rats; total lifetime use beyond two years is generally not recommended.